60
Views
28
CrossRef citations to date
0
Altmetric
Original Article

An International Review of Methadone Provision in Prisons

&
Pages 85-97 | Published online: 11 Jul 2009

References

  • Advisory Committee on the Misuse of Drugs. AIDS and Drug Misuse Update. HMSO, London 1993
  • Anonymous. The crisis in Correctional Health Care: the impact of the National Drug Control Strategy on Correctional Health Services. American College of Physicians, National Commission on Correctional Health Care and American Correctional Health Services Association. Annals of Internal Medicine 1992; 117(1)71–7
  • Bernasconi S., Buechi M., Steiger S. AIDS Prevention in a Swiss Prison: A pilot Project including the distribution of sterile injection equipment. Presentation at the Tenth International Conference on AIDS., Yokohama, 1994, Abstract no. PD0523 pp336
  • Bertram S., Gorta A. Views of recidivists released after participating in the NSW prison methadone program and the problems they faced in the community. Evaluation of the NSW Department of Corrective Services Prison Methadone Program Study no.8. Research Publication Department of Corrective Services. 1990, Publication no.21
  • Bertram S., Gorta A. Inmates' perceptions of the role of the NSW prison methadone program in preventing the spread of Human Immunodeficiency Virus. Evaluation of NSW Department of Corrective Services Prison Methadone Program. Study no.9. Research and Statistics Division. 1990
  • Bertram S. Results of Gaols Urinalyses Update: July-December 1989. Evaluation of NSW Department of Corrective Services Pre-release Methadone Program Study no. 10. Research and Statistics Division. 1991
  • Blix O., Gronbladh L. AIDS and the IV Heroin Addicts: The preventive effects of methadone maintenance in Sweden. Drug and Alcohol Dependence 1981; 7: 249–256
  • Brewer T. F., Derrickson J. AIDS in prison: a review of epidemiology and preventive policy. AIDS 1992; 6: 623–628
  • Brewer T. E, Vlahov D., Taylor E., Hall D., Munoz A., Polk F. Transmission of HIV-1 within a statewide prison system. AIDS 1988; 2: 363–367
  • Brown P. Chief Executive Officer. Corrections Health Service. 1994, Personal Communication
  • Caplehorn J. R. M., Dalton M. S., Guff M. C., Petrenas A. M. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994; 89: 203–7
  • Castro K., Shansky R., Scardino V., Narkunas J., Coe J., Hammett T. HIV Transmission in Correctional Facilities. Presentation at the Vllth International Conference on AIDS. Florence 1991; 314, Abstract no. M.C. 3067
  • Centers for Disease Control. Acquired Immunodeficiency Syndrome in correctional facilities: a report of the National Institute of Justice and the American Correctional Association. MMWR 1986; 35(12)195–199
  • Choopanya K. AIDS and drug addicts in Thailand. Bangkok Metropolitan Authority Department of Health, Bangkok 1989
  • Crofts N., Stewart T., Hearne P., Yi Ping X., Breschkin A. M., Locarnini S. A. Spread of blood borne viruses among Australian prison entrants. British Medical Journal 1995; 310: 285–288
  • Darke S., Ross J., Cohen J., Hall W. Context and correlates of non-fatal overdose among heroin users in Sydney. National Drug and Alcohol Research Centre. 1994, Monograph no.20
  • de Jong W. National AIDS Commission. Personal Communication. Amsterdam 1994
  • Directorate of the Drug Offensive of NSW Department of Health. Policies and Procedures for the Methadone Treatment of Opioid Dependence in. NSW. 1989
  • Dolan K., Wodak A., Hall W., Gaughwin M., Rae F. HIV risk behaviour before, during and after imprisonment in New South Wales. In press. Addiction Research
  • Dolan K., Hall W., Wodak A. Bleach Availability and Risk Behaviour in Prison in New South Wales. Technical Report No 22. National Drug and Alcohol Research Centre, Sydney, Sydney 1995
  • Dolan K., Kaplan E., Wodak A., Hall W., Gaughwin M. Modelling HIV Transmission in NSW Prisons, Australia. Presentation at the Tenth International Conference on AIDS., Yokohama, 1994; 336, Abstract no. PD0524
  • Dolan K., Hall W., Wodak A., Gaughwin M. Evidence of HIV transmission in an Australian prison. Letter MJA 1994; 160: 734
  • Dolan K. Sex in the Slammer. National AIDS Bulletin. Australian Federation of AIDS Organisations 1994c; 8(6)12–13
  • Dolan K. (1994) The Reduction of Risk Behaviour Among Prisoners in Methadone Maintenance Treatment in NSW. Presentation at the Australian and New Zealand Society of Criminology's 10th Annual Conference. September, 27-301994. UNSW, Sydney
  • Dolan K. A. Drug injectors in Prison and the community in England. International Journal of Drug Policy 1993; 4(4)179–183
  • Dolan K. A., Stimson G. V., Donoghoe M. C. Reductions in HIV risk behaviour and stable HIV prevalence in syringe-exchange clients and other injectors in England. Drug and Alcohol Review 1993; 12: 133–142
  • Dolan K. A. HIV in British prisons: Problems, risk behaviours and prevention. HIV/AIDS and Prisons. Conference Proceedings No. 4, J. Norberry, M. Gaughwin, S. A. Gerull. Australian Institute of Criminology, Canberra 1991
  • Dolan K. A., Donoghoe M., Stimson G. Drug injecting and syringe sharing in custody and in the community: an exploratory survey of HIV risk behaviour. The Howard Journal 1990a; 29(3)177–186
  • Dolan K. A., Donoghoe M. C, Jones S. G., Stimson G. V. A Cohort Study of Clients at Four Syringe Exchange Schemes and Comparisons Groups of Drug Injectors. Interim Report to the Department of Health. Monitoring Research Group, The Centre for Research on Drugs and Health Behaviour. Charing Cross and Westminster Medical School, London 1990
  • Dole V. P., Robinson J. W., Orraca J., Towns E., Searcy P., Caine E. Methadone treatment of randomly selected criminal addicts. The New England Journal of Medicine 1969; 280(No. 25)1372–1375
  • Dooley E. Director of Prison Medical Services. Personal Communication. Ireland 1995
  • Edwards A. Senior Health Adviser. Department of Justice, New Zealand 1995
  • Emslie J., Taylor A., Goldberg D., Wrench J., Gruer L. HIV outbreak in a Scottish Prison: Intervention. Presentation at the Tenth International Conference on AIDS. Yokohama 1994, Abstract no. PD 0526
  • European Centre for the Epidemiological Monitoring of AIDS. Surveillance of AIDS/HIV in Europe, 1984-1994. Saint Maurice, France 1994
  • Federal Office of Public Health. HIV prevention in Switzerland: Targets, strategies, interventions. National AIDS Commission, Bern 1993
  • Gaunay W., Gido R. AIDS a demographic profile of New York State inmates mortalities 1981-1985. New York State Commission of Correction, New York 1986
  • Gerstein D. R., Johnson R. A., Harwood H. J., Suter N. Evaluating Recovery Services: The California Drug and Alcohol Treatment Assessment. General Report. Sacramento, California 1994
  • Gottheil E., Sterling R. C., Weinstein S. P. Diminished illicit drug use as a consequence of long-term methadone maintenance. Journal of Addictive Diseases 1993; 12(4)45
  • Gorta A. Results of Gaol Urinalyses January-June 1987 Process evaluation of NSW Department of Corrective Services Pre-release Methadone Program Study 4. Research and Statistics Division. 1987
  • Gorta A. Monitoring the NSW prison methadone program: A review of the research 1986-1991. Research Publication Department of Corrective Services. 1992, Publication no. 25
  • Hall W., Ward J., Mattick R. Methadone maintenance in prison: The New South Wales experience. Drug and Alcohol Review 1993; 12: 193–203
  • Harding T., Schaller G. HIV/AIDS and Prisons: update and policy review. University Institute of Legal Medicine, Geneva 1992
  • Hearn P. Medical Director. HM Prison Pentridge, Victoria 1995
  • Herzog C, Fasnacht M., Stohler R., Ladewig D. (1993) Methadone substitution as an AIDS-preventive measure in the prison environment. Paper presented at the European Symposium on Drug Addiction & AIDS. October, 4-61993. SienaItaly
  • Horsburgh C. R., Jarvis J. Q., McArthur T, Ignacio T., Stock P. Seroconversion to Human Immunodeficiency virus in prison inmates. American Journal of Public Health 1990; 80(2)209–10
  • Hull H. F, Lyons L. H., Mann J. M., Hadler S. C, Steece R., Skeels M. R. Incidence of hepatitis B in the penitentiary of New Mexico. American Journal of Public Health 1985; 75(10)1213–1214
  • Hume S., Gorta A. Views of key personnel involved with the administration of the prison methadone program. Process evaluation of NSW Department of Corrective Services Prison Methadone Program. Research and Statistics Division. 1988
  • International Narcotic Control Board. International Narcotics Control Board. New York 1993, E/INCB/1993/1
  • Jeanmonod R., Harding T., Staub C. Treatment of opiate withdrawal on entry to prison. British Journal of Addiction 1991; 86(4)457–463
  • Jeffries S. Personal communication. Corrections Health Service, Sydney 1995
  • Klang L. Chief Medical Director, Swedish Prison and Probation Administration, Personal communication. 1995
  • Liew C. Director of Prison Medical Service, Personal Communication. 1995
  • Maden A., Swinton M., Gunn J. Drug dependence in prison. British Medical Journal 1990; 302: 880
  • Magura S. Personal communication. New York 1995
  • Magura S., Rosenblum A., Lewis C., Joseph H. The effectiveness of in-jail methadone maintenance. Journal of Drug Issues 1993; 23(1)75–99
  • Mann J. M., Tarantola D. J. M., Netter T. W. AIDS in the world: The global AIDS policy coalition. Harvard University Press, Cambridge 1992
  • Marco A. Department de Justicia. Spain 1995, Personal Communication
  • McDonald A., Grayson L., Frewin S., Bazin P., Todd B., Liew C, Harvey W., Hearne P., Fitzgerald P., Kaldor J. Testing for HIV antibody at reception into Australian prisons, 1991-1993. Abstract 10th Annual Conference. The Australian & New Zealand Society of Criminology, 1994
  • Mattick R. P., Hall W. A treatment outline for approaches to opioid dependence. Quality assurance in the treatment of drug dependence project. Australian Government Publishing Service, CanberraAustralia 1993
  • Medley G., Dolan K. A., Stimson G. A model of HIV transmission by syringe sharing in English prisons using surveys of injecting drug users. Presentation at the VIIIth International Conference on AIDS. Amsterdam 1992; 75, Abstract number MoD 0038
  • Mieczkowski T, Landress H. J., Newel R., Coletti S. Testing hair for illicit drug use. National Institute of Justice Research in Brief. US Department of Justice. 1993
  • Miner M., Gorta A. Heroin use in the lives of women prisoners in Australia. Australian and New Zealand Journal of Criminology 1987; 20(1)3–15
  • Ministerio de Justicia e Interior. Memoria. Delegacion del Gobierno para el Plan nacional sobre Droras. Madrid 1993
  • Mutter R. C, Grimes R. M., Labarthe D. Evidence of intraprison spread of HIV infection. Archives of Internal Medicine 1994; 154: 793–795
  • Newman R. G., Bashkow S., Cates M. Arrest histories before and after admission to a methadone maintenance program. Contemporary Drug Problems, Fall 1973; 7: 417–430
  • National Institute on Drug Abuse. Community Alert Bulletin. NIDA US Department of Health and Human Services. 1993, March 25
  • Novick D. M., Joseph H., Croxson T. S., Salsitz E. A., Wang G., Richman B. L., Poretsky L., Keefe J. B., Whimbey E. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Arch Intern Med 1990; 150: January
  • Potter F., Conolly L. AIDS–The sexual and IV drug use behaviour of prisoners. Research and Statistics Division, NSW Department of Corrective Services. 1990
  • Rhodes T. J., Bloor M. J., Donoghoe M. C, Haw S., Ettorre B., Piatt S., Frischer M., Hunter G. M., Taylor A., Finlay A., Crosier A. N., Stephens S., Covell R., Stimson G. V., Goldberg D. J., Green S. T, McKeganey N. P., Parry J. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow. AIDS Care 1993; 5(4)413–425
  • Rosenblum A., Magura S., Joseph H. Ambivalence toward methadone treatment among intravenous drug users. Journal of Psychoactive Drugs 1991; 23(1)21–27
  • Scottish Affairs Committee. Drug abuse in Scotland, Report. HMSO, London 1994
  • Seamark R., Gaughwin M. Jabs in the dark: Injecting equipment found in prisons, and the risks of viral transmission. Australian Journal of Public Health 1994; 18(1)113–116
  • Shapshank P., McCoy C. B., Rivers J. E., Chitwood D. D., Mash D. C, Weatherby N. L., Inciardi J. A., Shah S. M., Brown B. S. Inactivation of Human Immunodeficiency Virus -1 at short time intervals using undiluted bleach. Journal of Acquired Immune Deficiency Syndromes 1993; 6: 218–219
  • Shewan D., Macpherson S., Reid M., Davies J. B. Evaluation of the Saughton Drug Reduction Programme. Main Report. Central Research Unit, Edinburgh 1994
  • Stimson G. Drug injecting and HIV infection: New directions for social science research. International Journal of the Addictions 1992; 27(2)147–163
  • Taylor A., Goldberg D., Cameron S., Emslie J. Outbreak of HIV in a Scottish prison. Presentation at the Tenth International Conference on AIDS. Yokohama 1994; 43, Abstract no. 463C
  • Turnbull P. J., Dolan K. A., Stimson G. V. Prisons, HIV and AIDS: Risks and experiences in custodial care. Avert, HorshamEngland 1991
  • Turnbull P. J., Stimson G. V., Stillwell G. Drug use in prison. Avert, HorshamEngland 1994
  • van Hoeven K. H., Rooney W. C, Joseph S. C. Evidence of gonococcal transmission within a correctional system. American Journal of Public Health 1990; 80(12)1505–1506
  • Vlahov D., Polk F. Intravenous drug use and human immunodeficiency virus (HIV) infection in prison. AIDS and Public Policy Journal 1988; 3(2)42–46
  • Voumard S. Jail death: Nurses' guidelines faulted. Sydney Morning Herald. 1995; 6
  • Wale S., Gorta A. Views of inmates participating in the pilot pre-release methadone program. Process evaluation of NSW Department of Corrective Services Pre-release Methadone Program Study no. 2. Research and Statistics Division. 1987
  • Ward J., Mattick R., Hall W. Key issues in methadone maintenance treatment. University of New South Wales Press, Sydney 1992
  • Wiesfuse I. HIV-1 Infection among New York City inmates. Presentation at the VII International Conference on AIDS. Florence 1991
  • Wodak A. Behind bars: HIV risk taking behaviour of Sydney male IDUs injectors while in prison. Conference proceedings HIV/AIDS, J. Prison, M. Norberry, S. A. Gaughwin, Gerull. Australian Institute of Criminology, Canberra 1990
  • Wool R. Caring for drug misusers, Directorate of Health Care. Prison Service Library, Abel House, London 1991
  • World Health Organization. WHO guidelines on HIV infection and AIDS in prisons. WHO, Geneva 1993
  • Zador D., Sunjic S., Darke S. Toxicological findings and circumstances of heroin caused deaths in New South Wales in 1992. Monograph no. 22. National Drug and Alcohol Research Centre, Sydney 1995

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.